Key Findings:  The review suggests there is abundant preclinical literature demonstrating the anti-inflammatory effects of cannabinoid drugs in inflammation of the gut. Larger randomised controlled-trials are warranted. Cannabidiol, a phytocannabinoid, was the most investigated drug.
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  United Kingdom
Year of Pub:  2018
Cannabinoids Studied:  Cannabidiol (CBD), Cannabigerol (CBG), AM-x Synthetic Cannabinoids, WIN-x Synthetic Cannabinoids, Anandamide (AEA), Cannabinoid (unspecified), Synthetic Cannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable